We aimed to evaluate the performance of the Khorana score in predicting venous
thromboembolic events in ambulatory cancer patients. Embase and MEDLINE were …

Background This study aimed to summarize the previously published literature on the role of
platelet-to-lymphocyte ratio (PLR) on overall survival (OS) in patients with gastric cancer …

Background Pre-treatment PLR (platelet-lymphocyte ratio) was reported to be associated
with the prognosis in gastric cancer (GC), but the results remain inconclusive. This meta …

Introduction Recent studies attribute promising prognostic values to various inflammatory
biomarkers in acute pancreatitis, including the following: the neutrophil–lymphocyte ratio …

Stomach cancer (GC) has one of the highest rates of thrombosis among cancers and can
lead to considerable morbidity, mortality, and additional costs. However, to date, there is no …

Low Serum Ionized Calcium, Elevated High-Sensitivity C-Reactive Protein, Neutrophil-Lymphocyte
Ratio, and Body Mass Index (BMI) Are Risk Factors for Severe Acute Pancreatitis in Patients …

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and
pulmonary embolism (PE), has been an important cause of sudden in-hospital death …

Neutrophil-to-lymphocyte ratio (NLR), platelet-lymphocyte ratio, the systemic immune-
inflammation index (SII), and red blood cell distribution width (RDW), have been recognized …

Background Hepatocellular carcinoma (HCC) is increasingly common, potentially fatal
cancer type globally. Platelet-lymphocyte ratio (PLR) as a biomarker for systemic …

Cancer patients experience an increased risk of venous thromboembolism (VTE). In this
study, we investigated a risk of venous thromboembolism algorithm (RVTA) in patients with …